Eikon Therapeutics, Inc.
EIKN
$8.87
-$0.11-1.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 512.18M | 335.98M | 220.11M | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 16.92M | 12.54M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 400.00K | 400.00K | -- | ||
| Total Current Assets | 529.50M | 348.92M | -- | ||
|
|
|||||
| Total Current Assets | 529.50M | 348.92M | -- | ||
| Net Property, Plant & Equipment | 229.13M | 233.86M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 8.36M | 11.95M | -- | ||
| Total Assets | 850.83M | 594.73M | -- | ||
|
|
|||||
| Total Accounts Payable | 6.01M | 681.00K | -- | ||
| Total Accrued Expenses | 29.22M | 44.16M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 9.74M | 10.03M | -- | ||
| Total Finance Division Other Current Liabilities | 102.00K | 137.00K | -- | ||
| Total Other Current Liabilities | 102.00K | 137.00K | -- | ||
| Total Current Liabilities | 45.06M | 55.01M | -- | ||
|
|
|||||
| Total Current Liabilities | 45.06M | 55.01M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 245.09M | 247.29M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 10.00M | 10.00M | -- | ||
| Total Liabilities | 300.16M | 312.30M | -- | ||
|
|
|||||
| Common Stock & APIC | 1.55B | 41.48M | -- | ||
| Retained Earnings | -1.00B | -920.51M | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 550.67M | -879.03M | -571.93M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 1.16B | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 1.16B | 808.22M | ||
|
|
|||||
| Total Common Equity | 550.67M | -879.03M | -571.93M | ||
| Total Preferred Equity | -- | 1.16B | 808.22M | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 550.67M | 282.44M | 236.29M | ||
|
|
|||||